0001628280-26-008601
SEC filingOrion Engineered Carbons S.A. (OEC) reported net sales of $1.81 billion for fiscal year 2025, with gross profit of $359.8 million. The company recorded a net loss of $70.1 million, primarily driven by an $80.8 million goodwill impairment charge and $62.3 million in net interest expense. Despite the net loss, operating cash flow was strong at $215.8 million, supporting capital expenditures of $161.0 million. The balance sheet shows total assets of $1.91 billion, with total liabilities of $1.52 billion and stockholders' equity of $384.6 million. The company maintained a cash position of $60.7 million while carrying significant debt, including $305.0 million in current debt portion and $674.5 million in long-term debt. The financial results reflect challenging market conditions and the impact of the goodwill impairment on profitability.
Orion Engineered Carbons S.A. reported net sales of $1.81 billion for fiscal year 2025, with cost of sales totaling $1.45 billion, resulting in gross profit of $359.8 million. The company recorded income from operations of $27.5 million, but after accounting for $62.3 million in net interest expense and $35.8 million in income tax expense, the company reported a net loss of $70.1 million. Key factors impacting profitability included an $80.8 million goodwill impairment charge and $27.5 million in research and development costs. The company generated basic and diluted loss per share of $1.00 based on 56.3 million weighted-average shares outstanding.
The financial data provided does not include segment breakdown or geographic mix information. The company reported net sales of $1.81 billion for the fiscal year, but no further details about revenue composition, growth drivers, or segment performance are available in the provided data. The absence of segment data limits the ability to analyze revenue sources, product mix, or geographic contributions to overall sales performance.
The company achieved a gross margin of 19.9% based on $359.8 million gross profit from $1.81 billion in net sales. Operating margin was 1.5% with $27.5 million in operating income. The cost structure shows selling, general and administrative expenses of $230.7 million (12.7% of revenue) and research and development costs of $27.5 million (1.5% of revenue). The $80.8 million goodwill impairment significantly impacted profitability, representing 4.5% of revenue. The company also recorded a $6.9 million recovery from misappropriation of assets.
The company generated strong operating cash flow of $215.8 million despite the net loss, primarily due to $131.9 million in depreciation and amortization and $80.8 million in impairment charges. Free cash flow was $54.8 million after deducting $161.0 million in capital expenditures. The balance sheet shows total assets of $1.91 billion, including $643.8 million in current assets and $1.07 billion in net property, plant and equipment. Total liabilities were $1.52 billion, with $626.4 million in current liabilities and $896.6 million in non-current liabilities. The company had $60.7 million in cash and cash equivalents with total debt of $979.5 million ($305.0 million current portion, $674.5 million long-term).
The provided financial data does not include management guidance, strategic priorities, or specific risk factors. The filing shows the company invested $161.0 million in property, plant and equipment during the year, indicating ongoing capital investment. The company paid $4.7 million in dividends to stockholders and repurchased $24.8 million of common stock. The $80.8 million goodwill impairment suggests potential challenges in certain business areas, but no forward-looking statements or outlook information is available in the provided data.